The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
Hendrik UngefrorenDavid WitteChristian FiedlerThomas GädekenRoland KaufmannHendrik LehnertFrank GieselerBernhard H RauchPublished in: International journal of molecular sciences (2017)
Inhibition of ERK signaling with the MEK inhibitor U0126 blunted the ability of TGF-β1 to induce migration in pancreatic cancer Panc1 cells. ERK activation in response to PAR2 agonistic peptide (PAR2-AP) was strong and rapid, while it was moderate and delayed in response to TGF-β1. Basal and TGF-β1-dependent ERK, but not SMAD activation, was blocked by U0126 in Panc1 and other cell types indicating that ERK activation is downstream or independent of SMAD signaling. Moreover, cellular depletion of PAR2 in HaCaT cells strongly inhibited TGF-β1-induced ERK activation, while the biased PAR2 agonist GB88 at 10 and 100 µM potentiated TGF-β1-dependent ERK activation and cell migration. Finally, we provide evidence for a physical interaction between PAR2 and ALK5. Our data show that both PAR2-AP- and TGF-β1-induced cell migration depend on ERK activation, that PAR2 expression is crucial for TGF-β1-induced ERK activation, and that the functional cooperation of PAR2 and TGF-β1 involves a physical interaction between PAR2 and ALK5.
Keyphrases
- transforming growth factor
- signaling pathway
- pi k akt
- cell proliferation
- cell migration
- epithelial mesenchymal transition
- induced apoptosis
- cell cycle arrest
- high glucose
- diabetic rats
- stem cells
- escherichia coli
- poor prognosis
- transcription factor
- cell therapy
- staphylococcus aureus
- single cell
- advanced non small cell lung cancer
- endothelial cells
- bone marrow
- biofilm formation
- big data
- pseudomonas aeruginosa
- epidermal growth factor receptor